- Report
- December 2023
- 353 Pages
Global
From €4778EUR$4,950USD£4,098GBP
- Report
- August 2023
- 122 Pages
Europe
From €5743EUR$5,950USD£4,926GBP
- Book
- March 2022
- 896 Pages
Recombinant Antibodies are a type of antibody produced through genetic engineering. They are used in a variety of applications, including diagnostics, therapeutics, and research. In genomics, recombinant antibodies are used to detect and quantify proteins, nucleic acids, and other molecules. They are also used to study gene expression, protein-protein interactions, and other biological processes. Recombinant antibodies are produced by cloning and expressing antibody genes in a variety of expression systems, such as bacteria, yeast, and mammalian cells.
Recombinant antibodies are becoming increasingly important in the genomics field, as they provide a more accurate and reliable way to detect and quantify molecules. They are also more cost-effective than traditional methods, such as immunoassays.
Some companies in the recombinant antibodies market include Abcam, Bio-Rad, Merck, Thermo Fisher Scientific, and GenScript. Show Less Read more